Supernus to expand CNS portfolio with Sage Therapeutics acquisition
The acquisition allows Supernus to add ZURZUVAE, an FDA-approved oral treatment for postpartum depression, to its product lineup.
Mitsubishi, Astellas partner to support pharma startups in Japan
J&J unveils promising data for dual-targeting CAR T therapy
AstraZeneca, China-based CSPC partner to develop novel oral therapies
BioNTech to acquire mRNA drugmaker CureVac for up to $1.25bn
Moderna secures FDA expanded approval for mRESVIA RSV vaccine
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry